Johnson & Johnson Stops HIV Vaccine Trial In African Women

Johnson & Johnson Stops HIV Vaccine Trial In African Women: Johnson & Johnson (NYSE: JNJ) and a consortium of global partners announced results from the primary analysis of a Phase 2b HIV vaccine trial, Imbokodo study....